Novavax To Launch Clinical Trial Of Ebola Vaccine; Sarepta Announces Update On Eteplirsen By: TalkMarkets October 28, 2014 at 05:14 AM EDT Novavax, Inc. will launch a Phase 1 clinical trial of an Ebola vaccine candidate in December. Read More >> Related Stocks: Novavax Inc Sarepta Therapeutics